Zobrazeno 1 - 10
of 583
pro vyhledávání: '"anti-TNF agents"'
Autor:
Jihye Park, Jae Hee Cheon
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 5, Pp 895-905 (2022)
The incidence and prevalence of inflammatory bowel diseases (IBDs) are rapidly increasing worldwide. IBDs are considered an emerging problem not only in Western countries but also in developing counties. The relapses and complications of active IBD m
Externí odkaz:
https://doaj.org/article/06b90a1663b34e9dbb03961ed495223a
Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundThere are few studies on medical conditions associated with the development of drug-resistant TB.ObjectiveWe investigated the risk factors for the occurrence of multidrug-resistant (MDR) tuberculosis (TB) in patients with pulmonary TB.Mater
Externí odkaz:
https://doaj.org/article/9fb835873a3d4effac0f911bdf899cc6
Autor:
Swetalina Pradhan, Bhushan Madke, Shekhar Neema, Poonam Kabra, Adarsh Lata Singh, Sangita Yadav
Publikováno v:
Indian Journal of Dermatology, Vol 66, Iss 5, Pp 501-507 (2021)
Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This pa
Externí odkaz:
https://doaj.org/article/909f9f252bdd4bcfa4b8e4c7c49c8415
Autor:
Nuria Carballo, Enric Garcia-Alzórriz, Olivia Ferrández, María Eugenia Navarrete-Rouco, Xavier Durán-Jordà, Carolina Pérez-García, Jordi Monfort, Francesc Cots, Santiago Grau
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/a844882bca9e45eea66000bbcc3e751b
Autor:
Vu Q. Nguyen, Kristin Eden, Holly A. Morrison, Megan B. Sammons, Kristin K. Knight, Siena Sorrentino, Rebecca M. Brock, Douglas J. Grider, Irving C. Allen, Dario Sorrentino
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objectives: Targeting tumor necrosis factor (TNF) with biologic agents, such as infliximab and adalimumab, is a widely used and effective therapeutic strategy in inflammatory bowel disease (IBD). Unfortunately, a significant number of patients fail t
Externí odkaz:
https://doaj.org/article/f89bfa1765c74f868f346d8327726b48
Autor:
Maria Luque-Tévar, Carlos Perez-Sanchez, Alejandra Mª Patiño-Trives, Nuria Barbarroja, Ivan Arias de la Rosa, Mª Carmen Abalos-Aguilera, Juan Antonio Marin-Sanz, Desiree Ruiz-Vilchez, Rafaela Ortega-Castro, Pilar Font, Clementina Lopez-Medina, Montserrat Romero-Gomez, Carlos Rodriguez-Escalera, Jose Perez-Venegas, Mª Dolores Ruiz-Montesinos, Carmen Dominguez, Carmen Romero-Barco, Antonio Fernandez-Nebro, Natalia Mena-Vazquez, Jose Luis Marenco, Julia Uceda-Montañez, Mª Dolores Toledo-Coello, M. Angeles Aguirre, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez, Chary Lopez-Pedrera
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Background: This prospective multicenter study developed an integrative clinical and molecular longitudinal study in Rheumatoid Arthritis (RA) patients to explore changes in serologic parameters following anti-TNF therapy (TNF inhibitors, TNFi) and b
Externí odkaz:
https://doaj.org/article/bb017e91ba5d4f1ebf7fe17dc8217b1e
Autor:
Alessandra Soriano, Marco Soriano, Gerard Espinosa, Raffaele Manna, Giacomo Emmi, Luca Cantarini, José Hernández-Rodríguez
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Monogenic autoinflammatory diseases are rare conditions caused by genetic abnormalities affecting the innate immunity. Previous therapeutic strategies had been mainly based on results from retrospective studies and physicians' experience. However, du
Externí odkaz:
https://doaj.org/article/c8d41556e4d341fc87137ff2f675ab6a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 0910 (2019)
Ocular inflammations such as uveitis and scleritis can lead to significant visual impairment if not treated properly. To limit potentially sight-threatening complications, good control of the inflammation in the acute phase is necessary. Corticostero
Externí odkaz:
https://doaj.org/article/a3e13a79a06d4a0a8205853f0c7f33b0
Autor:
Milou Ohm, Joeri W. van Straalen, Marieke Zijlstra, Gerrie de Joode-Smink, Anne Jasmijn Sellies, Joost F. Swart, Sebastiaan J. Vastert, Joris M. van Montfrans, Marije Bartels, Annet van Royen-Kerkhof, Joanne G. Wildenbeest, Caroline A. Lindemans, Victorien Wolters, Roos A.W. Wennink, Joke H. de Boer, Mirjam J. Knol, Marloes W. Heijstek, Elisabeth A.M. Sanders, Frans M. Verduyn-Lunel, Guy A.M. Berbers, Nico M. Wulffraat, Marc H.A. Jansen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d6cfbea085a9f343dae63c6f79f6c5b
http://hdl.handle.net/10029/626709
http://hdl.handle.net/10029/626709
